• Passa al contenuto principale
BC

biochimica clinica

it_IT Italian
it_IT Italian en_US English
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

CASI CLINICI – Case Reports

Volume:

Biochimica Clinica 2012; 36(3) 196-203

Pubblicato on-line:

DOI:

Scarica in PDF:
Autenticazione richiesta

Il D-dimero nella pratica di laboratorio

AUTORI

Armando Tripodi
Centro Angelo Bianchi Bonomi per l’Emofilia e la Trombosi, Dipartimento di Medicina Interna, IRCCS Ca' Granda Ospedale Maggiore Policlinico e Università degli Studi di Milano, Milano

ABSTRACT

D-Dimer Testing in Laboratory Practice

D-Dimer is a reliable and sensitive index of fibrin deposition and stabilization. As such, its presence in plasma should be indicative of thrombus formation. There are many conditions unrelated to thrombosis in which D-dimer concentrations are high, however, making its positive predictive value rather poor. Notwithstanding these limitations, D-dimer can be regarded as a most valuable laboratory tool to diagnose and manage a vast array of thrombosisrelated clinical conditions, including (a) diagnosis of venous thromboembolism (VTE), (b) identification of individuals at increased risk of first thrombotic event (both arterial and venous), (c) identification of individuals at increased risk of recurrent VTE, (d) establishment of the optimal duration of secondary prophylaxis after a first episode of VTE, (e) pregnancy monitoring, and (f) diagnosis/monitoring of disseminated intravascular coagulation (DIC). This article is aimed at reviewing the merits and pitfalls of these applications. From my analysis of the literature, I draw the following conclusions: (a) D-dimer, as measured by a sensitive test, can be safely used to exclude VTE in symptomatic outpatients, provided that it is used in combination with the pretest clinical probability; (b) high concentrations of Ddimer are associated with an increased risk of recurrent VTE; (c) patients who present with D-dimer above cut-off after stopping the regular course of oral anticoagulation benefit from extended prophylaxis; (d) finally, D-dimer can be used as a fibrin-related degradation marker for the diagnosis/management of patients with DIC.

BIBLIOGRAFIA

HOME
PRIVACY POLICY
5x1000 Docemus

LOGO SIBioC

EDITORE RESPONSABILE
Alberto Oliaro

EDITORIAL SECRETARY
Edizioni Minerva Medica S.p.A.
Corso Bramante 83-85, 10126 Torino
T +39 011 678282
journals.dept@minervamedica.it

Designed by Biomedia srl
© 2025 SIBioC
P. IVA IT 06484860967